Streetbeat News

SCNX

Scienture Holdings, Inc.

https://www.trxadehealth.com

Industry

Medical - Healthcare Information Services

TRxADE HEALTH, Inc. operates as health services IT company. It offers an online web-based buying and selling platform for licensed pharmaceutical wholesalers to sell brand, generic, and non-drug products and services to government organizations, hospitals, clinics and independent pharmacies. TRxADE HEALTH, Inc. is headquartered in Tampa, Florida.

Open

3.06

Mkt cap

14M

Volume

63M

High

3.17

P/E Ratio

-0.08

52-wk high

25.80

Low

1.53

Div yield

0.94

52-wk low

1.00

Scienture Holdings (NASDAQ: SCNX) has drawn on its Equity Line of Credit to support the launch of Arbli™ Oral Suspension. The company has temporarily suspended further draws until its stock reaches $10/share or after 30 trading days.

Portfolio Pulse from

March 19, 2025 | 12:15 pm

Portfolio Pulse from

March 19, 2025 | 12:15 pm

SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX) has received FDA approval for its new product, ArbliTM, a losartan potassium oral suspension. This is the first FDA-approved ready-to-use oral liquid losartan in the U.S., targeting hypertension, stroke risk reduction, and diabetic nephropathy.

Portfolio Pulse from

March 18, 2025 | 12:15 pm

Portfolio Pulse from

March 18, 2025 | 12:15 pm

Scienture Holdings, Inc. (NASDAQ: SCNX) announced that Dr. Narasimhan Mani will participate as a speaker and panelist at the 8th Annual Conference of The Society for the Study of Xenobiotics in India, focusing on drug discovery and development.

Portfolio Pulse from

January 21, 2025 | 1:15 pm

Scienture Holdings, Inc. (NASDAQ: SCNX) will participate in The Microcap Conference 2025, a key event for growth-focused companies and investors, scheduled for January 28-30, 2025, in Atlantic City, NJ.

Portfolio Pulse from

December 17, 2024 | 1:30 pm

Scienture Holdings, Inc. (NASDAQ: SCNX) announced that its subsidiary, Scienture, LLC, has been granted a new patent for its product SCN-102, extending its patent coverage through 2041. This strengthens the company's intellectual property position.

Portfolio Pulse from

December 10, 2024 | 1:30 pm

TRxADE Health, Inc. has rebranded to Scienture Holdings, Inc. and changed its Nasdaq ticker symbol from 'MEDS' to 'SCNX'. The company will continue to operate as a pharmaceutical product company through its subsidiaries.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 12:29 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.